JOST Werke (JST) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 sales reached €298.2 million, with €21 million from M&A; adjusted EBIT was €33.8 million, maintaining an 11.3% margin despite softer markets.
Free cash flow for H1 2024 was €61 million, up 80.2% year-over-year; leverage remained below 1x after a €22 million dividend payment.
Adjusted EPS for H1 was €3.07; adjusted net earnings to sales ratio stood at 7.8%.
Strategic investment of €15–50 million for a 10% stake in Trailer Dynamics to strengthen R&D in eTrailer technology.
ROCE reached around 20% and cash conversion rate was 1.3 in H1 2024, reflecting strong shareholder value.
Financial highlights
Organic sales declined 17% in Europe, 22% in North America, and 2% in Asia Pacific, Africa.
European sales fell to €166.5 million in Q2, a 6.2% reported decline; EBIT dropped from €14.3 million to €8.3 million.
North America saw a 22% organic sales decline but achieved a 17.4% Q2 EBIT margin, driven by premium loaders and strong aftermarket.
Asia Pacific Africa reported a 1.3% sales decline; EBIT decreased 10% to €9.8 million, mainly due to mix effects.
Group sales declined 10% reported and 16% organically; adjusted EBIT margin held at 11.3%.
Outlook and guidance
2024 sales and adjusted EBIT expected to decline single digits from 2023, with EBIT margin in the upper half of the 10–11.5% strategic corridor.
CapEx to remain between 2.5% and 2.9% of sales; working capital below 19% of sales.
Market outlook revised downward for trucks and tractors; trailer markets expected to stabilize.
Ag market recovery anticipated in 2025 as dealer inventories normalize.
Asia-Pacific-Africa expected to remain stable or grow slightly.
Latest events from JOST Werke
- Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation5 Mar 2026 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update22 Jan 2026 - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 202421 Jan 2026 - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement20 Jan 2026 - Despite sales declines, strong cash flow and key acquisitions support future growth.JST
Q3 202414 Jan 2026 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 202417 Dec 2025 - Q2 2025 sales up 31% on Hyva deal, with 2025 outlook reaffirmed despite margin pressure.JST
Q2 202523 Nov 2025 - Hyva acquisition drove 25% Q1 sales growth, with strong cash flow and higher leverage.JST
Q1 202521 Nov 2025 - Q3 2025 revenue up 55.6% on Hyva integration and organic growth; outlook confirmed.JST
Q3 202513 Nov 2025